SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Costantino who wrote (3478)1/27/1998 8:34:00 PM
From: Hank   of 4342
 
Rick,

Two points here. 1) I don't think you'll see anymore empoyee cut backs. After all, I think there was only a secretary and Tachovsky left when Biomar stepped in. Not much room for down sizing.

2) They apparently intent to market the herbs INTACT. Androvir and Androcar were purified components of Andorgraphis P. Since the whole herb is not a purified "pharmaceutical" per se, they intend to side skirt the FDA ruling by selling the crude substance. It's a strategy that may work from an FDA approval viewpoint but I doubt the end product will have the same medical benefit as the purified components would have. Hence, a slim market potential IMHO.

Hank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News